Quantcast
Last updated on April 16, 2014 at 11:49 EDT

Latest Pulmonology Stories

2013-06-14 12:26:44

-- First approved therapy for IPF patients in Italy will be reimbursed from June 29 -- BRISBANE, Calif., June 14, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that the Board of the Italian Drug Agency (AIFA) has approved the pricing and reimbursement conditions for Esbriet(®) (pirfenidone), and that the agreement has been published in the Official Gazette, the official journal of the government of Italy. Esbriet is InterMune's product for the treatment of...

2013-06-07 16:24:09

MADISON, Wis., June 7, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-?-lis), the FDA-cleared mobile health solution for asthma and COPD, today announces it received a second investment from the California HealthCare Foundation (CHCF). Asthmapolis is designed to improve the care of people with asthma and COPD, advance understanding of symptoms and triggers and help them achieve control of these diseases. The CHCF investment in Asthmapolis, which now totals $1,047,000, is directed at helping to...

2013-06-05 08:27:36

SAN DIEGO, June 5, 2013 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today the measured advantages of inhaled GP-101 (aerosol pirfenidone) in the treatment of pulmonary fibrosis. Utilizing the standard in vivo model of bleomycin-induced pulmonary fibrosis, we have demonstrated that small inhaled doses yielding high peak, short duration lung pirfenidone...

2013-05-28 12:26:31

Change Policy to Allow ALL Approved Patients Under 12 to Receive New Lungs Based on Need PHILADELPHIA, May 28, 2013 /PRNewswire/ -- In response to a public statement from the organizations that regulate organ distribution saying they "cannot create a policy exception for one patient," devoted parents Fran and Janet Murnaghan have renewed their commitment to fight the policy that prevents children under 12 from receiving adult transplant lungs based on need. The Murnaghans'...

2013-05-22 23:03:10

The mission of the Lung Nodule Center is to provide the best chance for curing lung cancer by early diagnosis and expeditious, state-of-the-art lung cancer care. Sleepy Hollow, New York (PRWEB) May 22, 2013 Phelps Memorial Hospital Center in Sleepy Hollow, New York, has established the Westchester Lung Nodule Center for individuals who would like to be screened for lung nodules or receive lung cancer care. Lung cancer is the deadliest form of cancer for both men and women. Each year, more...

Almost Half Of COPD Diagnoses Are Wrong
2013-05-22 12:56:06

Peter Suciu for redOrbit.com — Your Universe Online A new study has found that chronic obstructive pulmonary disease (COPD) is over-diagnosed among uninsured patients. Researchers found that over 40 percent of patients being treated for COPD at federally funded clinics did not actually have the disease. COPD is a progressive lung disease that leads to the loss of lung function and is primarily caused by smoking. The disease causes coughing, wheezing, shortness of breath, chest...

2013-05-22 10:22:52

Research into genetic features of pulmonary fibrosis by physicians and scientists at the University of Colorado School of Medicine may lead to improved treatment of this deadly lung disease, according to a paper published online by JAMA. The study found that a particular genetic variation helps predict survival in some cases of pulmonary fibrosis, a chronic progressive disease with a median survival of three years. As a result of the study, researchers may want to consider including...

2013-05-22 10:19:08

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibrosis can be used to identify individuals at risk for this deadly lung disease. Researchers looked at a fairly common variant of the gene for mucin-5B, a protein that is a component of the mucous produced by the bronchial tubes. While this variant of the MUC5B gene is...

2013-05-22 04:21:01

OXFORD, England, May 22, 2013 /PRNewswire/ -- First patients dosed with PSX1002, an orally inhaled, novel drug-only formulation of glycopyrronium bromide designed using Prosonix' particle engineering platform Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung...

2013-05-21 12:28:25

NATICK, Mass., May 21, 2013 /PRNewswire/ -- Five-year data from the Asthma Intervention Research 2 (AIR2) clinical trial presented today demonstrated that the Boston Scientific Corporation (NYSE: BSX) Alair(® )Bronchial Thermoplasty (BT) System continues to show therapy benefits in adult patients with severe uncontrolled asthma. Bronchial Thermoplasty was shown to provide long term asthma control, demonstrated by a sustained reduction in the rate of severe exacerbations (asthma attacks)...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »